ST. PETERSBURG, USA

St. Petersburg is our primary softgel development and manufacturing facility in North America with capacity of 18 billion capsules per year. The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candicates. Non-gelatin based OptiShell® and Vegicaps® capsules expand the range of molecules into softgel, ideal for challenging fill formulation. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges.

Size: 453,000 ft²

CAPABILITIES:

• Formulation Development and Manufacturing services for:
  • Controlled Substances
  • Highly Potent Compounds
  • Hormones
• Rx and OTC Softgel development and manufacturing

FEATURED TECHNOLOGIES:

• OptiForm® Solution Suite
• OptiShell® Technology
• RP Scherer Softgel Technology
• Vegicaps® Capsules

ACCREDITATIONS

• EMA/MHRA Approved
• FDA Approved
• ANVISA
• PMDA
• CFDA (China)
• MOH (Saudi Arabia, Turkey)
• MFDS

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

CAREERS

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume.